Burke William Patrick - Jan 3, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Human Resources Officer
Signature
By: /s/ Kimberly Burke, Attorney in Fact for William Patrick Burke
Stock symbol
NVCR
Transactions as of
Jan 3, 2022
Transactions value $
-$267
Form type
4
Date filed
1/5/2022, 03:52 PM
Previous filing
Sep 3, 2021
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $200K +17.5K +66.57% $11.46 43.7K Jan 3, 2022 Direct F1
transaction NVCR Ordinary Shares Sale -$200K -2.63K -6.03% $75.96 41K Jan 3, 2022 Direct F1
transaction NVCR Ordinary Shares Options Exercise $69.7K +9.75K +23.76% $7.15* 50.8K Jan 3, 2022 Direct F1
transaction NVCR Ordinary Shares Sale -$69.9K -919 -1.81% $76.09 49.9K Jan 3, 2022 Direct F2
transaction NVCR Ordinary Shares Options Exercise $30.3K +1.4K +2.81% $21.60 51.3K Jan 3, 2022 Direct F1
transaction NVCR Ordinary Shares Sale -$30.3K -399 -0.78% $76.03 50.9K Jan 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -17.5K -100% $0.00* 0 Jan 3, 2022 Ordinary Shares 17.5K $11.46 Direct F3
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -9.75K -100% $0.00* 0 Jan 3, 2022 Ordinary Shares 9.75K $7.15 Direct F3
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1.4K -18.69% $0.00 6.1K Jan 3, 2022 Ordinary Shares 1.4K $21.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke.
F2 On January 3, 2022, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke, Mr. Burke sold 919 shares in multiple trades at prices ranging from $76.00 to $76.09. The price reported above reflects the weighted average sale price. Mr. Burke hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3 Fully vested as of the date hereof.